Research ArticleArticle
Magnetic Resonance Imaging Compared to Conventional Radiographs for Detection of Chronic Structural Changes in Sacroiliac Joints in Axial Spondyloarthritis
Denis Poddubnyy, Inna Gaydukova, Kay-Geert Hermann, In-Ho Song, Hildrun Haibel, Jürgen Braun and Joachim Sieper
The Journal of Rheumatology July 2013, jrheum.130141; DOI: https://doi.org/10.3899/jrheum.130141
Denis Poddubnyy
From the Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Berlin, Germany; Department of Hospital Therapy, Saratov State Medical University, Saratov, Russian Federation; Department of Radiology, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany; and Rheumazentrum Ruhrgebiet, Herne, Germany. Investigator-initiated trials that served as a source of data for this study were supported by Abbott GmbH & Co. KG, Essex Pharma GmbH (now MSD Sharp & Dohme GmbH), and Wyeth Pharma GmbH (now Pfizer Deutschland GmbH). Additionally supported by ArthroMark (grant no. FKZ 01EC1009A) and ANCYLOSS (grant no. FKZ 01EC1002D) projects funded by the German Federal Ministry of Education and Research. Dr. Gaydukova was supported by a fellowship of the Assessment of Spondyloarthritis International Society (ASAS). D. Poddubnyy, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin; I. Gaydukova, MD, Department of Hospital Therapy, Saratov State Medical University; K-G. Hermann, MD, Department of Radiology, Campus Mitte, Charité Universitätsmedizin Berlin; I-H. Song, MD; H. Haibel, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin; J. Braun, MD, Rheumazentrum Ruhrgebiet; J. Sieper, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin. Dr. Poddubnyy and Dr. Gaydukova contributed equally to this work. Address correspondence to Dr. D. Poddubnyy, Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Hindenburgdamm 30, 12203 Berlin, Germany. E-mail: denis.poddubnyy@charite.de Accepted for publication May 9, 2013.
Inna Gaydukova
From the Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Berlin, Germany; Department of Hospital Therapy, Saratov State Medical University, Saratov, Russian Federation; Department of Radiology, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany; and Rheumazentrum Ruhrgebiet, Herne, Germany. Investigator-initiated trials that served as a source of data for this study were supported by Abbott GmbH & Co. KG, Essex Pharma GmbH (now MSD Sharp & Dohme GmbH), and Wyeth Pharma GmbH (now Pfizer Deutschland GmbH). Additionally supported by ArthroMark (grant no. FKZ 01EC1009A) and ANCYLOSS (grant no. FKZ 01EC1002D) projects funded by the German Federal Ministry of Education and Research. Dr. Gaydukova was supported by a fellowship of the Assessment of Spondyloarthritis International Society (ASAS). D. Poddubnyy, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin; I. Gaydukova, MD, Department of Hospital Therapy, Saratov State Medical University; K-G. Hermann, MD, Department of Radiology, Campus Mitte, Charité Universitätsmedizin Berlin; I-H. Song, MD; H. Haibel, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin; J. Braun, MD, Rheumazentrum Ruhrgebiet; J. Sieper, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin. Dr. Poddubnyy and Dr. Gaydukova contributed equally to this work. Address correspondence to Dr. D. Poddubnyy, Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Hindenburgdamm 30, 12203 Berlin, Germany. E-mail: denis.poddubnyy@charite.de Accepted for publication May 9, 2013.
Kay-Geert Hermann
From the Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Berlin, Germany; Department of Hospital Therapy, Saratov State Medical University, Saratov, Russian Federation; Department of Radiology, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany; and Rheumazentrum Ruhrgebiet, Herne, Germany. Investigator-initiated trials that served as a source of data for this study were supported by Abbott GmbH & Co. KG, Essex Pharma GmbH (now MSD Sharp & Dohme GmbH), and Wyeth Pharma GmbH (now Pfizer Deutschland GmbH). Additionally supported by ArthroMark (grant no. FKZ 01EC1009A) and ANCYLOSS (grant no. FKZ 01EC1002D) projects funded by the German Federal Ministry of Education and Research. Dr. Gaydukova was supported by a fellowship of the Assessment of Spondyloarthritis International Society (ASAS). D. Poddubnyy, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin; I. Gaydukova, MD, Department of Hospital Therapy, Saratov State Medical University; K-G. Hermann, MD, Department of Radiology, Campus Mitte, Charité Universitätsmedizin Berlin; I-H. Song, MD; H. Haibel, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin; J. Braun, MD, Rheumazentrum Ruhrgebiet; J. Sieper, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin. Dr. Poddubnyy and Dr. Gaydukova contributed equally to this work. Address correspondence to Dr. D. Poddubnyy, Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Hindenburgdamm 30, 12203 Berlin, Germany. E-mail: denis.poddubnyy@charite.de Accepted for publication May 9, 2013.
In-Ho Song
From the Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Berlin, Germany; Department of Hospital Therapy, Saratov State Medical University, Saratov, Russian Federation; Department of Radiology, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany; and Rheumazentrum Ruhrgebiet, Herne, Germany. Investigator-initiated trials that served as a source of data for this study were supported by Abbott GmbH & Co. KG, Essex Pharma GmbH (now MSD Sharp & Dohme GmbH), and Wyeth Pharma GmbH (now Pfizer Deutschland GmbH). Additionally supported by ArthroMark (grant no. FKZ 01EC1009A) and ANCYLOSS (grant no. FKZ 01EC1002D) projects funded by the German Federal Ministry of Education and Research. Dr. Gaydukova was supported by a fellowship of the Assessment of Spondyloarthritis International Society (ASAS). D. Poddubnyy, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin; I. Gaydukova, MD, Department of Hospital Therapy, Saratov State Medical University; K-G. Hermann, MD, Department of Radiology, Campus Mitte, Charité Universitätsmedizin Berlin; I-H. Song, MD; H. Haibel, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin; J. Braun, MD, Rheumazentrum Ruhrgebiet; J. Sieper, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin. Dr. Poddubnyy and Dr. Gaydukova contributed equally to this work. Address correspondence to Dr. D. Poddubnyy, Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Hindenburgdamm 30, 12203 Berlin, Germany. E-mail: denis.poddubnyy@charite.de Accepted for publication May 9, 2013.
Hildrun Haibel
From the Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Berlin, Germany; Department of Hospital Therapy, Saratov State Medical University, Saratov, Russian Federation; Department of Radiology, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany; and Rheumazentrum Ruhrgebiet, Herne, Germany. Investigator-initiated trials that served as a source of data for this study were supported by Abbott GmbH & Co. KG, Essex Pharma GmbH (now MSD Sharp & Dohme GmbH), and Wyeth Pharma GmbH (now Pfizer Deutschland GmbH). Additionally supported by ArthroMark (grant no. FKZ 01EC1009A) and ANCYLOSS (grant no. FKZ 01EC1002D) projects funded by the German Federal Ministry of Education and Research. Dr. Gaydukova was supported by a fellowship of the Assessment of Spondyloarthritis International Society (ASAS). D. Poddubnyy, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin; I. Gaydukova, MD, Department of Hospital Therapy, Saratov State Medical University; K-G. Hermann, MD, Department of Radiology, Campus Mitte, Charité Universitätsmedizin Berlin; I-H. Song, MD; H. Haibel, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin; J. Braun, MD, Rheumazentrum Ruhrgebiet; J. Sieper, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin. Dr. Poddubnyy and Dr. Gaydukova contributed equally to this work. Address correspondence to Dr. D. Poddubnyy, Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Hindenburgdamm 30, 12203 Berlin, Germany. E-mail: denis.poddubnyy@charite.de Accepted for publication May 9, 2013.
Jürgen Braun
From the Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Berlin, Germany; Department of Hospital Therapy, Saratov State Medical University, Saratov, Russian Federation; Department of Radiology, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany; and Rheumazentrum Ruhrgebiet, Herne, Germany. Investigator-initiated trials that served as a source of data for this study were supported by Abbott GmbH & Co. KG, Essex Pharma GmbH (now MSD Sharp & Dohme GmbH), and Wyeth Pharma GmbH (now Pfizer Deutschland GmbH). Additionally supported by ArthroMark (grant no. FKZ 01EC1009A) and ANCYLOSS (grant no. FKZ 01EC1002D) projects funded by the German Federal Ministry of Education and Research. Dr. Gaydukova was supported by a fellowship of the Assessment of Spondyloarthritis International Society (ASAS). D. Poddubnyy, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin; I. Gaydukova, MD, Department of Hospital Therapy, Saratov State Medical University; K-G. Hermann, MD, Department of Radiology, Campus Mitte, Charité Universitätsmedizin Berlin; I-H. Song, MD; H. Haibel, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin; J. Braun, MD, Rheumazentrum Ruhrgebiet; J. Sieper, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin. Dr. Poddubnyy and Dr. Gaydukova contributed equally to this work. Address correspondence to Dr. D. Poddubnyy, Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Hindenburgdamm 30, 12203 Berlin, Germany. E-mail: denis.poddubnyy@charite.de Accepted for publication May 9, 2013.
Joachim Sieper
From the Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Berlin, Germany; Department of Hospital Therapy, Saratov State Medical University, Saratov, Russian Federation; Department of Radiology, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany; and Rheumazentrum Ruhrgebiet, Herne, Germany. Investigator-initiated trials that served as a source of data for this study were supported by Abbott GmbH & Co. KG, Essex Pharma GmbH (now MSD Sharp & Dohme GmbH), and Wyeth Pharma GmbH (now Pfizer Deutschland GmbH). Additionally supported by ArthroMark (grant no. FKZ 01EC1009A) and ANCYLOSS (grant no. FKZ 01EC1002D) projects funded by the German Federal Ministry of Education and Research. Dr. Gaydukova was supported by a fellowship of the Assessment of Spondyloarthritis International Society (ASAS). D. Poddubnyy, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin; I. Gaydukova, MD, Department of Hospital Therapy, Saratov State Medical University; K-G. Hermann, MD, Department of Radiology, Campus Mitte, Charité Universitätsmedizin Berlin; I-H. Song, MD; H. Haibel, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin; J. Braun, MD, Rheumazentrum Ruhrgebiet; J. Sieper, MD, Department of Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin. Dr. Poddubnyy and Dr. Gaydukova contributed equally to this work. Address correspondence to Dr. D. Poddubnyy, Rheumatology, Medical Department I, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Hindenburgdamm 30, 12203 Berlin, Germany. E-mail: denis.poddubnyy@charite.de Accepted for publication May 9, 2013.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Magnetic Resonance Imaging Compared to Conventional Radiographs for Detection of Chronic Structural Changes in Sacroiliac Joints in Axial Spondyloarthritis
Denis Poddubnyy, Inna Gaydukova, Kay-Geert Hermann, In-Ho Song, Hildrun Haibel, Jürgen Braun, Joachim Sieper
The Journal of Rheumatology Jul 2013, jrheum.130141; DOI: 10.3899/jrheum.130141
Magnetic Resonance Imaging Compared to Conventional Radiographs for Detection of Chronic Structural Changes in Sacroiliac Joints in Axial Spondyloarthritis
Denis Poddubnyy, Inna Gaydukova, Kay-Geert Hermann, In-Ho Song, Hildrun Haibel, Jürgen Braun, Joachim Sieper
The Journal of Rheumatology Jul 2013, jrheum.130141; DOI: 10.3899/jrheum.130141